Rajesh Kumar Subaschandrabose

Title: Innovations by Rajesh Kumar Subaschandrabose

Introduction

Rajesh Kumar Subaschandrabose is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on addressing critical health challenges, such as influenza viruses.

Latest Patents

Rajesh Kumar Subaschandrabose holds a patent for "Monoclonal antibodies targeting neutralizing epitopes on H7 influenza viruses." This invention relates to the murine monoclonal antibody (mAb) 11B9 and mAb 62, which target major neutralizing epitopes of influenza A H7 hemagglutinin and active fragments thereof. The patent also encompasses methods and compositions for the prophylaxis and treatment of H7 influenza using these antibodies or their fragments. Additionally, it includes methods and kits for determining, identifying, and quantifying influenza A hemagglutinin in samples or vaccines.

Career Highlights

Throughout his career, Rajesh has worked with esteemed organizations, including Temasek Life Sciences Laboratories Limited and Temasek Life Sciences Laboratory Limited. His experience in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Rajesh has collaborated with notable colleagues, including Hwei-Sing Jimmy Kwang and Fang He. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Rajesh Kumar Subaschandrabose is a distinguished inventor whose work on monoclonal antibodies has the potential to improve treatments for influenza. His contributions to biotechnology reflect his commitment to advancing health solutions.